Inventor
ENGEL JUERGEN
DE91 patents
⚠️ This page may combine multiple inventors who share the name “ENGEL JUERGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTA MEDICA AG
23 patentsUS5556856ASep 17, 1996
Phthalazinone derivatives that modulate multi-drug resistance
ASTA MEDICA AG56 citations95
US6436924B2Aug 20, 2002
Antihistamine leukotriene combinations
ASTA MEDICA AG33 citations92
US6022860AFeb 8, 2000
Immobilized and activity-stabilized complexes of LHRH antagonists and processes for their preparation
ASTA MEDICA AG60 citations92
US5985834ANov 16, 1999
Nova- and decapeptides in the preparation of a drug for the treatment of aids
ASTA MEDICA AG50 citations92
US5503845AApr 2, 1996
Tablets, granulates and pellets with a high active substance content for highly concentrated, solid dosage forms
ASTA MEDICA AG20 citations92
US5376382ADec 27, 1994
Tablets, granulates and pellets with a high active substance content for highly concentrated, solid dosage forms of thioctic acid
ASTA MEDICA AG35 citations92
US6300313B1Oct 9, 2001
Means for treating prostate hypertrophy and prostate cancer
ASTA MEDICA AG17 citations91
US6172050B1Jan 9, 2001
Phospholipid derivatives
ASTA MEDICA AG17 citations91
US5521178AMay 28, 1996
Combination medication containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence
ASTA MEDICA AG30 citations91
US5773032AJun 30, 1998
Long-acting injection suspensions and a process for their preparation
ASTA MEDICA AG45 citations90
US7022687B1Apr 4, 2006
Combination of loteprednol and antihistamines
ASTA MEDICA AG27 citations89
US5405847AApr 11, 1995
4,5-dihydro-4-oxo-pyrrolo[1,2-a]quinoxalinones and corresponding aza analogs and a process for their preparation
ASTA MEDICA AG26 citations89
US6093704AJul 25, 2000
Use of dopamine receptor antagonists in palliative tumor therapy
ASTA MEDICA AG13 citations82
US5728738AMar 17, 1998
Injectable mesna solutions
ASTA MEDICA AG15 citations79
US5721258AFeb 24, 1998
Primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases
ASTA MEDICA AG11 citations73
US6071882AJun 6, 2000
Means for treating prostate hypertrophy and prostate cancer
ASTA MEDICA AG7 citations72
US6054432AApr 25, 2000
Means for treating prostate hypertrophy and prostate cancer
ASTA MEDICA AG7 citations72
US5998377ADec 7, 1999
Means for treating prostate cancer
ASTA MEDICA AG9 citations72
US5219866AJun 15, 1993
Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its preparation
ASTA MEDICA AG10 citations72
US5464838ANov 7, 1995
Aminocarboxylic acid derivatives having antiallergic/antiasthmatic effect and a process for their preparation
ASTA MEDICA AG7 citations71
US5446033AAug 29, 1995
Stabilized hexadecylphosphocholine solutions in glycerol alkyl ethers
ASTA MEDICA AG11 citations71
US6106805AAug 22, 2000
Diagnostic composition containing an LH-RH antagonist for hysteroscopy
ASTA MEDICA AG6 citations70
US6054555AApr 25, 2000
Process for the preparation of immobilized and activity-stabilized complexes of LHRH antagonists
ASTA MEDICA AG13 citations70
ASTA PHARMA AG
8 patentsUS5232919AAug 3, 1993
Azelastine embonate and compositions which contain it
ASTA PHARMA AG51 citations96
US5728735AMar 17, 1998
Pharmaceutical composition containing R-α-lipoic acid or S-α-lipoic acid as active ingredient
ASTA PHARMA AG73 citations95
US6271254B1Aug 7, 2001
Pharmaceutical compositions containing R-α-lipoic acid or S-α-lipoic acid as active ingredient
ASTA PHARMA AG26 citations92
US5084481AJan 28, 1992
Method of treating inflammatory diseases with pharmaceutical composition containing dihydrolipoic acid as active substance
ASTA PHARMA AG39 citations92
US4923858AMay 8, 1990
Substituted 3-(n-heterocyclic)-2,6-diaminopyridines and -n-oxides
ASTA PHARMA AG27 citations92
US5110814AMay 5, 1992
Azelastine and its salts used to combat psoriasis
ASTA PHARMA AG27 citations89
US5023335AJun 11, 1991
1,2-bis (aminomethyl) cyclobutane-platinum complexes
ASTA PHARMA AG32 citations89
US5290769AMar 1, 1994
Use of hexadecylphosphocholine for the treatment of psoriasis
ASTA PHARMA AG15 citations73
ZENTARIS GMBH
4 patentsUS7214662B2May 8, 2007
Injectable solution of an LHRH antagonist
ZENTARIS GMBH33 citations89
US7871977B2Jan 18, 2011
Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
ZENTARIS GMBH9 citations84
US6867191B2Mar 15, 2005
Preparation and use of oligopeptide lyophilisate for gonad protection
ZENTARIS GMBH6 citations73
US6828415B2Dec 7, 2004
Oligopeptide lyophilisate, their preparation and use
ZENTARIS GMBH8 citations73
ZENTARIS AG
4 patentsUS6319192B1Nov 20, 2001
Method for the treatment of fertility disorders
ZENTARIS AG18 citations83
US6863891B2Mar 8, 2005
Oligopeptide lyophilisate, their preparation and use
ZENTARIS AG4 citations73
US6696428B2Feb 24, 2004
Use of dopamine receptor antagonists in palliative tumor therapy
ZENTARIS AG9 citations73
US6544551B1Apr 8, 2003
Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis
ZENTARIS AG7 citations71
DEGUSSA
3 patentsUS4547505AOct 15, 1985
N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
DEGUSSA43 citations87
US4335126AJun 15, 1982
1-[3-(3,4,5-Trimethoxyphenoxy)-2-hydroxy-propyl]-4-aryl-piperazine-derivatives having pharmaceutical activity
DEGUSSA15 citations73
US4785110ANov 15, 1988
Process for the production of 2-amino-3-nitro-6-(4-fluorobenzylamino)-pyridine
DEGUSSA7 citations72
ASTA WERKE AG CHEM FAB
2 patentsAASTA PHARMA AG
1 patentFREUDENBERG CARL FA
1 patentVIATRIS GMBH
1 patentBAXTER HEALTHCARE SA
1 patentMAX PLANCK GESELLSCHAFT
1 patentZIOPHARM ONCOLOGY INC
1 patentShowing the top 50 of 91 patents by PatentIndex Score.